Therapeutic Asset Ratings
263 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Theprubicin
Hepatocellular Carcinoma
RWTH Aachen University
P4
BB
(71)
Calcium folinate pentahydrate
Hepatocellular Carcinoma
Li Qiang
P4
BB
(70)
Eloxatin
Hepatocellular Carcinoma
Li Qiang
P4
BB
(70)
Ethiodized Oil
Hepatocellular Carcinoma
RWTH Aachen University
P4
BB
(70)
FLUOROURACILUM
Hepatocellular Carcinoma
Li Qiang
P4
BB
(70)
Inno-206
Hepatocellular Carcinoma
VA Office of Research and Development
P4
BB
(70)
Epirubicin
Hepatocellular Carcinoma
Fudan University
P4
BB
(69)
LENVATINIB
Hepatocellular Carcinoma
Zhejiang Haichang Biotech Co., Ltd.
P4
BB
(69)
Sorafenib
Hepatocellular Carcinoma
Shunda Du
P4
BB
(69)
Donafenib
Hepatocellular Carcinoma
Haibo Shao
P4
BB
(68)
Irinotecan
Hepatocellular Carcinoma
Icahn School of Medicine at Mount Sinai
P4
BB
(68)
Cyclophosphamide
Hepatocellular Carcinoma
Roswell Park Cancer Institute
P3
BB
(68)
Pembrolizumab
Hepatocellular Carcinoma
Fudan University
P3
BB
(68)
Raltitrexed
Hepatocellular Carcinoma
Fudan University
P3
BB
(68)
Atezolizumab
Hepatocellular Carcinoma
Icahn School of Medicine at Mount Sinai
P4
BB
(67)
(+)-VINCRISTINE
Hepatocellular Carcinoma
Icahn School of Medicine at Mount Sinai
P4
BB
(67)
Idarubicine
Hepatocellular Carcinoma
Hoffmann-La Roche
P3
BB
(67)
Bms-907351
Hepatocellular Carcinoma
Exelixis
P4
BB
(66)
Carboplatin
Hepatocellular Carcinoma
University of Texas Southwestern Medical Center
P4
BB
(66)
Ivonescimab
Hepatocellular Carcinoma
Akeso
P4
BB
(66)
Rivoceranib
Hepatocellular Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P3
BB
(66)
Tislelizumab
Hepatocellular Carcinoma
Haibo Shao
P4
BB
(65)
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
Hepatocellular Carcinoma
Fudan University
P3
BB
(65)
Nivolumab
Hepatocellular Carcinoma
Zhejiang Haichang Biotech Co., Ltd.
P3
BB
(65)
Zanzalintinib
Hepatocellular Carcinoma
Exelixis
P3
BB
(65)
Showing 1 to 25 of 263 assets
Previous
Page 1 of 11
Next